| scholarly article | Q13442814 |
| P953 | full work available at URL | http://www.jimmunol.org/cgi/content/abstract/155/10/4917 |
| P698 | PubMed publication ID | 7594496 |
| P2093 | author name string | A. Aruffo | |
| P. A. Kiener | |||
| A. F. Wahl | |||
| D. Hollenbaugh | |||
| P. Moran-Davis | |||
| B. M. Rankin | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4917-4925 | |
| P577 | publication date | 1995-11-01 | |
| 1995-11-15 | |||
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes | |
| P478 | volume | 155 |
| Q38737500 | ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis |
| Q36733758 | Activation of human monocytes induces differential resistance to apoptosis with rapid down regulation of caspase-8/FLICE. |
| Q83921113 | Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients |
| Q35786333 | Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation |
| Q35176320 | CD154 transcriptional regulation in primary human CD4 T cells |
| Q51840948 | CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells. |
| Q41812728 | CD4 T cells and their role in antitumor immune responses |
| Q36414862 | CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis |
| Q37377899 | CD40 and the immune response to parasitic infections |
| Q35011537 | CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity |
| Q36629448 | CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer |
| Q40594560 | CD40 in Retinal Müller Cells Induces P2X7-Dependent Cytokine Expression in Macrophages/Microglia in Diabetic Mice and Development of Early Experimental Diabetic Retinopathy |
| Q26752784 | CD40 in coronary artery disease: a matter of macrophages? |
| Q34128815 | CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes |
| Q36065955 | CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines |
| Q36400640 | CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum |
| Q35793488 | CD40 ligation induces tissue factor expression in human vascular smooth muscle cells |
| Q34919840 | CD40 promotes the development of early diabetic retinopathy in mice |
| Q34002117 | CD40-CD40 ligand interactions augment survival of normal mice, but not CD40 ligand knockout mice, challenged orally with Salmonella dublin |
| Q37091615 | CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-kappaB (NFkappaB) and activator protein-1 (AP-1) |
| Q35688370 | CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4. |
| Q28216904 | CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes |
| Q47115358 | CD40L Expression Allows CD8+ T Cells to Promote Their Own Expansion and Differentiation through Dendritic Cells. |
| Q27666816 | Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation |
| Q42112392 | Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages |
| Q36994261 | Downregulation of CD40 ligand response in monocytes from sepsis patients |
| Q35133638 | Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis |
| Q35096745 | EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine |
| Q63560435 | Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates |
| Q33551709 | Enhancement of Mycobacterium tuberculosis-induced tumor necrosis factor alpha production from primary human monocytes by an activated T-cell membrane-mediated mechanism |
| Q36375676 | FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis |
| Q37374541 | Functional CD40 ligand is expressed by T cells in rheumatoid arthritis |
| Q36028683 | Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis |
| Q36375414 | Immunoglobulin A1 protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines. |
| Q34005446 | Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV. |
| Q39518137 | Influence of costimulatory molecules on immune response to Leishmania major by human cells in vitro |
| Q35160907 | Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice |
| Q28198287 | Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis |
| Q80562648 | Lipopolysaccharide desensitizes monocytes-macrophages to CD40 ligand stimulation |
| Q36417432 | Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. |
| Q50044364 | Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy |
| Q43182095 | New frontiers for platelet CD154. |
| Q37297601 | Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways |
| Q80454607 | Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway |
| Q33602274 | Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot |
| Q33839665 | Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry |
| Q36114898 | Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF). |
| Q36539633 | Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis |
| Q88830574 | Relationship Between Plasma Levels of Soluble CD40 Ligand and the Presence and Severity of Isolated Coronary Artery Ectasia |
| Q27480732 | Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo |
| Q33877154 | Role of CD40 ligand in Mycobacterium avium infection |
| Q77627732 | Role of pro-inflammatory cytokines in rheumatoid arthritis |
| Q46275241 | Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome. |
| Q34981885 | Soluble CD40 ligand and prolactin levels in migraine patients during interictal period |
| Q34108813 | T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules |
| Q41361342 | The CD40 ligand. At the center of the immune universe? |
| Q92538952 | The CD40-ATP-P2X 7 Receptor Pathway: Cell to Cell Cross-Talk to Promote Inflammation and Programmed Cell Death of Endothelial Cells |
| Q36371081 | The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. |
| Q40716543 | The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes |
| Q47998036 | The hyper-IgM (HIM) syndrome |
| Q36934401 | The pathogenesis of sepsis. |
| Q31129671 | The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen |
| Q37518524 | The role of CD40 and CD154/CD40L in dendritic cells |
| Q41904511 | Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L. |
| Q35056748 | Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis |
| Q83984890 | Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha |
| Q34099462 | X-linked hyper IgM syndrome |
Search more.